Today: 9 June 2026
Experian share price rises after fresh buyback update as investors eye May results
17 February 2026
1 min read

Experian share price rises after fresh buyback update as investors eye May results

London, Feb 17, 2026, 08:23 (GMT) — Regular session

Experian PLC bounced back from a brief early slide, with shares up around 2.2% at 2,525 pence as of 0823 GMT. The latest buyback announcement from the credit data and analytics firm had investors recalibrating.

FTSE 100-listed firm disclosed it bought back 400,000 shares on Feb. 16 via J.P. Morgan Securities, shelling out a weighted average 2,509.9391 pence per share. The company uses buybacks like this to return capital to shareholders and trim its share count.

That buy forms part of Experian’s $1 billion share repurchase plan rolled out Jan. 30, the day the company reiterated no change to its medium-term financial framework, dividend policy or capital allocation. Buybacks like these have turned into a go-to signal for strong cash flows—especially now, with investors quick to punish on price.

The stock’s been volatile lately. Monday saw a 2.6% drop, despite the FTSE 100 ticking higher. It’s still trading roughly 40% under its 52-week peak of 41.01 pounds from July 18, according to MarketWatch data.

Chief Executive Brian Cassin, in the January trading update, said the group “delivered strong Q3 growth,” with full-year expectations sticking where they were. Experian

Traders have their eye on whether demand for credit checks and fraud detection sticks as lenders tweak underwriting and consumers face pressure from rates and employment. Since Experian reports in U.S. dollars, currency swings may show up in its headline growth.

Squeezing the share count with buybacks can push earnings per share higher. Still, they don’t solve sluggish lending or softer demand for data by themselves.

The risk is clear enough: if credit activity slows or delinquencies pick up faster than expected, usage-driven revenue takes a hit. Stricter regulations on consumer data might also limit how the firm puts its datasets to work. When that happens, investors usually shift their attention right back to growth and pricing power.

Experian is set to release its preliminary full-year numbers on May 20, then follows up with a first-quarter trading update slated for July 16.

Stock Market Today

  • NOV Stock Up 32% in Six Months: Key Factors and Investor Outlook
    June 9, 2026, 10:21 AM EDT. NOV Inc. shares have surged 31.5% over six months, outpacing the Mechanical and Equipment Oil and Gas sub-industry and broader energy sector. The company benefits from strong offshore equipment demand, driven by subsea flexible pipe growth and offshore projects through 2028. NOV's focus on automation and cost reduction, including headcount and facility cuts, supports operational efficiency. Management anticipates a multi-year upcycle in capital equipment spending due to energy security and renewed offshore investment, bolstering demand. With a solid backlog and positive 2026 earnings outlook, NOV's positioning suggests potential for continued gains, raising questions for investors on whether to hold or sell amid market shifts.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Previous Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Tesco share price nudges toward 52-week high after UK retail sales jump — what to watch next
Next Story

Tesco share price nudges toward 52-week high after UK retail sales jump — what to watch next

Go toTop